Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Never shake
You qualify for GLP-1 medications under FDA labeling without any additional conditions
Transient and mostly mild-to-moderate gastrointestinal symptoms were the most frequently reported AE and occurred more frequently with the 4 mg starting dose groups rather than the 2 mg starting dose groups [67]
"Not medically necessary" or "step therapy required" = PA denial (you can appeal) "Excluded benefit" or "not covered" = your plan's formulary differs from standard (request exception) WHAT'S COMING Aetna Coverage Outlook for 2026 Wegovy Coverage Expected to Continue in 2026 CVS Caremark's deal with Novo Nordisk positions Wegovy as the primary GLP-1 option for Aetna plans
Current weight
US$ 28.24
US$ 29.84
US$ 21.12
US$ 20.57
